Prostate Cancer - Results from #18780

Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer - Abstract April 3, 2015

Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies - Abstract April 2, 2015

Pathologic findings in patients who underwent robot-assisted radical prostatectomy following active surveillance: A prospective study in a single center - Abstract April 2, 2015

Natural history of surgically treated high-risk prostate cancer - Abstract April 2, 2015

Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results - Abstract April 2, 2015

Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy - Abstract April 2, 2015

Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer - Abstract April 2, 2015

Augmenix announces FDA clearance of SpaceOAR® System April 2, 2015

Cryoablation of prostate cancer - Abstract April 2, 2015

Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: Does sequencing matter? - Abstract April 2, 2015

Gleason upgrading with time in a large prostate cancer active surveillance cohort - Abstract April 2, 2015

Hypofractionated radiation therapy versus conventional radiation therapy in prostate cancer: A systematic review of its safety and efficacy - Abstract April 2, 2015

Does obesity modify the ability of pre-biopsy PSA to detect prostate cancer on repeat biopsy? Results from the REDUCE study - Abstract April 2, 2015

Present, emerging and possible future biomarkers in castration resistant prostate cancer (CRPC) - Abstract April 1, 2015

Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-Years experience - Abstract April 1, 2015

The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy - Abstract April 1, 2015

Adjuvant vs. salvage radiotherapy after radical prostatectomy - Abstract April 1, 2015

Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience - Abstract April 1, 2015

Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer - Abstract April 1, 2015

Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy - Abstract April 1, 2015

Page 940 of 1457